News Sentiment

LONN sentiment intelligence

Lonza Group AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 51 Balanced news tone 12 relevant articles
Exchange EBS Switzerland
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 498.70 Week of 19 Jun 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

92/100 classification confidence.

Company focus 12

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+1.7% over one week, +1.2% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Lonza Issues License to Antharis Therapeutics for ADCs

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 92/100 classification
One-week reaction 1.7% Price digesting
Trend fit Trend inactive 1.2% over four weeks
Fair value -0.7% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 11
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 12
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
simplywall.st 5
CHEManager 3
Bain Capital 2
The Globe and Mail 1
Market source 1

Event Lens

What the news is about

Classified themes
Market update 11
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-12 of 12